AMASS BRANDS (AMSS): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

AMASS BRANDS (AMSS) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 3.03 Material Modification to Rights of Security Holders. To the extent required by Item 3.03 of Form 8-K, the information contained in Item 5.03 of this Current Report on Form 8-K is incorporated by reference into this Item 3.03. Item 5.02. Departure of Directors or Certain

Original reporting
Published Oct 23, 2026, 9:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 23, 2026, 9:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$AMSS
Neutral
high confidence
Mentioned
$AMSS
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$AMSSNeutralMed
01

Why it matters

These corporate actions are material for the company, especially the CFO change and capital‑structure amendment, which could influence investor sentiment and share price in the short term.

02

Market read

The filing provides the first public disclosure of these changes, offering traders a fresh data point for short‑term positioning.

03

What to watch

The amendment lowering the preferred‑stock floor price may enable future conversions at lower prices, affecting dilution calculations.

Relevance 6/10Novelty 6/10Timing: effective November 16‑17, 2026

Background

AMASS Brands Inc. (AMSS) filed a Form 8‑K detailing executive departures, a new interim CFO appointment, amendments to its Series C convertible preferred stock, and the termination of a large warrant previously issued to an investor.

Company-level read

Ticker impact

$AMSSNeutralHigh confidence
Context

SEC 8‑K reports resignation of CFO Zachary Ament, appointment of interim CFO Geoffrey McFarlane, amendment to Series C preferred stock terms, and termination of a 3.5 M‑share warrant.

Expected impact

potential modest pressure as the market prices in leadership transition and the removal of a large warrant that could have added supply.

Evidence & confidence

Leadership changes and capital‑structure adjustments are material for a micro‑cap; no immediate cash outflow but market perception may shift.

Market effects

Limited to niche consumer‑goods and specialty beverage sector; no broader sector impact.

Company is US‑based; effects confined to its own stock.

Low

Counterpoint

The CFO transition could be seen as a positive sign if the interim CFO stabilizes operations, potentially supporting the stock.

Key entities

  • Zachary Ament

    Resigned CFO effective November 16, 2026.

  • Geoffrey McFarlane

    Appointed interim CFO effective November 17, 2026.

  • Streeterville Capital, LLC

    Investor whose 3.5 M‑share warrant was terminated.

Related articles

$AMSSMed

AMASS Brands Inc. Announces Preliminary Third Quarter 2026 Net Revenue of Approximately $5.3 Million, Up 30% Year-Over-Year

AMASS BRANDS (AMSS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 AMASS Brands Inc. Announces Preliminary Third Quarter 2026 Net Revenue of Approximately $5.3 Million, Up 30% Year-Over-Year Third Quarter Net Revenue Exceeds Guidance by Approximately 20% Preliminary Core Brand Net Revenue Grows approximately 67% While Preliminary No

$AMSSMed

AMASS Brands Inc. Reports Second Quarter 2026 Results

AMASS BRANDS (AMSS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 AMASS Brands Inc. Reports Second Quarter 2026 Results Core Brands Grow 12% While Non-Alcoholic & Functional Revenue More Than Doubles Portfolio Transformation Continues with New Retail Wins, Category Leadership and Functional Expansion Introduces Initial Financial Gu

$AMSSMedAI 8/10

AMASS Brands Group Secures First U.S. Distribution Partner for AMASS Electrolyte Mixers

AMASS Brands Group (NASDAQ: AMSS) said Great Lakes Wine & Spirits will become its first U.S. distribution partner for AMASS Electrolyte Mixers, launching the product across Michigan. Great Lakes, which distributes 6,000+ wine labels and 3,000+ spirits, will provide dedicated sales support via a new alternative/better-for-you division. The company said this creates its initial commercial footprint for national expansion.

$AMSSMedAI 8/10

AMASS Brands Group Launches AMASS Electrolyte Mixers, Expanding into the Functional Wellness Beverage Category

AMASS Brands Group (NASDAQ: AMSS) announced the launch of AMASS Electrolyte Mixers, ready-to-drink electrolyte products in cans formulated with Pacific sea salt and essential electrolytes, with 20 or fewer calories and zero added sugar or artificial sweeteners. The mixers can be used alone or as a mixer with alcohol or non-alcoholic spirits. The company says initial production is complete and distribution will expand through 2026.

$CVSMed

CVS Health announces plan to split into two companies

CVS Health plans to split into two publicly traded companies by early 2028, separating its retail pharmacy business from Aetna and CVS Caremark. The move follows a Tennessee law targeting healthcare giants like CVS, which owns both a pharmacy benefit manager and retail pharmacies. CVS is suing the state, claiming the law is unconstitutional. The company states the restructuring will not affect its Tennessee pharmacies or clinics.